The Study
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
This study is like a fair science experiment where people were randomly given either a medicine or a fake pill. It can tell us if the medicine really causes changes in kidney or heart problems, but only for the main question. When scientists look at smaller groups (like people with healthier kidneys), the results are more like clues, not proof.
Analysis score
Maximum 90 for a randomized controlled trial.
Where the score came from
A big study checked if a weekly diabetes medicine (exenatide) helps protect the eyes, kidneys, and heart in people with type 2 diabetes.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 582 / 100
Quality score
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Key takeaways
Summary
Based on the study abstract and findings.
- 1The results mean the medicine doesn’t clearly protect the kidneys or eyes, and any heart benefit is uncertain and likely small.
- 2The medicine didn’t meaningfully change kidney function (eGFR), didn’t lower eye disease risk, and didn’t clearly prevent kidney damage.
- 3It slightly reduced some kidney issues only after adjusting data.
- 4People with healthy kidneys had fewer heart problems, but this wasn’t strong proof.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Diabetes Care
Year
2019
Authors
M. A. Bethel, R. Mentz, P. Merrill, J. Buse, J. Chan, Shaun G. Goodman, Shaun G. Goodman, N. Iqbal, Neli Jakubonienė, B. Katona, Y. Lokhnygina, R. Lopes, A. Maggioni, P. Öhman, T. Tankova, G. Bakris, Adrian F. Hernandez, R. Holman
Related Content
Claims (6)
A diabetes drug made from Gila monster spit doesn't just help blood sugar — it can also help people lose weight, protect the heart, and even reduce cravings for things like alcohol or drugs.
Taking a weekly exenatide shot doesn’t really change how well your kidneys are working if you have type 2 diabetes — the numbers stayed about the same over time.
Taking a weekly exenatide shot doesn’t lower the chance of eye problems from diabetes, even if your blood sugar improves or you already had early eye issues.
Taking a weekly diabetes shot called exenatide doesn’t seem to lower the risk of a specific type of kidney problem in adults with type 2 diabetes — the numbers don’t show a clear benefit.
A weekly diabetes shot called exenatide doesn’t seem to lower the risk of serious kidney problems in adults with type 2 diabetes when looking at the raw data. But when researchers adjusted the numbers, it showed a small benefit when including a wider range of kidney issues, like high protein in the urine.
For people with type 2 diabetes and healthy kidneys, taking a weekly exenatide shot might slightly lower the risk of heart problems or dying, but the evidence isn't strong and hasn't been fully checked for other factors.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.